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a b s t r a c t
This case presents an episode of electrical storm (ES) in post-myocardial infarction patient
results from myocarditis. ES was interrupted by aneurysmectomy and additional isolation of
VT origins by radiofrequency catheter ablation. The histological evaluation of aneurysm
material proved acute myocarditis. The key ﬁndings indicating acute inﬂammation in
myocardium was an increased level of peripheral inﬂammatory biomarker IL6 and auto-
antibodies to beta1-adrenergic receptor (b1-AAbs). Gated SPECT with phase images analysis
turned out to be appropriate imaging strategy in visualizing potentially reversible causes of
ventricular arrhythmias such as myocarditis. Taking together our ﬁndings might add some
information on the pathogenesis and predisposing factors of ventricular arrhythmias
especially in the cases of electrical storm.
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Electrical storm (ES) is a life-threatening syndrome that is
deﬁned by three or more episodes of sustained ventricular
tachycardia (VT) or ventricular ﬁbrillation (VF) or appropriate
shocks from implantable cardioverter-deﬁbrillator (ICD) with-
in 24 h. The incidence of ES varies from 4% to 28% in different
studied populations. According to the MADIT-II substudy,
patients, who experienced ES, showed a 7.4-fold higher risk of
death compared with those without [1]. It is evident that ES is
associated with worse patient's outcome, however it is still
unclear whether their poor prognosis is a direct consequence
of ES or it is simply an epiphenomenon of advanced structural
heart disease [2].
A lot of attempts have been made in order to identify the
possible predictors of ES. Undoubtedly that it is strongly
associated with progressive heart failure (HF) [2]. Streitner F.
et al. showed that episodes of ES in patients with HF could be
predicted by elevated serum concentrations of inﬂammatory
biomarkers such as hs-CRP, NT-pro BNP and IL-6 [3]. On the
other hand the deterioration of HF itself can be accompanied
by elevation of inﬂammatory biomarkers as well as anticardiac
antibodies [4,5]. At the same time increased cytokine level and
persistence of autoantibodies to beta1-adrenergic receptor (b1-
AAbs) is usually observed in the serum of patients with
inﬂammatory cardiac pathology [5]. These biomarkers can
directly or indirectly worsen left ventricular (LV) function and
so trigger VTs [5,6] as well as reﬂect the ongoing inﬂammation
in myocardium.
One of clinical manifestations of myocarditis is new-onset
ventricular arrhythmias. Such arrhythmias are often related to
myocardial damage caused by toxic or viral as well as
autoimmune injury. Moreover inﬂammatory affection of
myocardium can additionally trigger arrhythmias also in
patients with pre-existing arrhythmogenic focuses as we
observed in presented case.
Case report
A 65-year old woman admitted to Intensive Care Unit of our
Hospital on February 2013 because of recurrent VT episodes
and multiple ICD shocks during the last three days.
The patient's history indicates that she survived from
acute anterior myocardial infarction (MI) in 2001 and was
clinically stable until the year 2012 on standard therapy. In
July 2012 the patient suffered from recurrent anterior MI,
which was complicated by sustained VT. That time the
patient underwent coronary angiography followed by of two
stents implantation in the left anterior descending artery.
Two months later the patient suffered from several episodes
of palpitations and presyncopes, that were documented on
ECG as VTs. Clinical examination showed symptoms relevant
to NYHA class II of heart failure. The echocardiography
revealed a large anterior-septal hypokinesis with an apical
aneurysm and signiﬁcantly decreased left ventricular ejec-
tion fraction (LVEF) (27%). Patient underwent ICD implanta-
tion for secondary prevention of SCD and was stable until
February 2013. It should be noted, that about two weeks beforethe onset of ES the patient had an episode of acute respiratory
infection.
On present admission to the hospital patient was hemody-
namically stable. She was on treatment with bisoprolol 5 mg/
daily, amiodarone 200 mg/daily, clopidogrel, statins, aspirin,
angiotensin converting enzyme (ACE) inhibitors and diuretics in
appropriate doses. The ICD interrogation revealed multiple
episodes of monomorphic VT with different QRS morphologies
and maximal heart rate of 220 b.p.m. and a single episode of VF.
Ventricular arrhythmias were successfully terminated by ICD.
Laboratory tests showed normal serum levels of thyroid
hormones, potassium, magnesium, hs-CRP. The troponin test
was negative. Polymerase chain reaction (PCR) revealed absent
of herpes simplex 1–2 virus, human herpes 6 virus, Epstein-
Barr virus, cytomegalovirus and parvovirus B19. The addition-
al evaluation of inﬂammatory biomarkers found negative
concentration of tumor necrosis factor alpha while the level of
interleukin 6 (IL6) exceeded reference ranges and was 14.8 pg/
ml. We also performed the evaluation of b1-AAbs in serum by
enzyme-linked immunosorbent assay. The level of b1-AAbs
was increase up to 7.2 (the normal values were considered to
be less than 1), indicating possible autoimmune component of
heart injury process.
Instrumental testing: The chest X-ray showed left ventricle
enlargement, no signs of pulmonary edema. Dual-chamber ICD
and electrodes were in normal position. Transthoracic echo-
cardiography showed dilated left ventricle (end diastolic
diameter (EDD) 6.7 cm, end diastolic volume (EDV) 268 ml) with
extensive anterior-septal hypokinesis, huge apical aneurysm,
accompanied by decreased LVEF (30%), moderate mitral
regurgitation and mild lung pulmonary hypertension (pulmo-
nary artery systolic pressure (PASP) 40 mmHg). Urgent coronary
angiography did not show any coronary artery lesions including
no evidence of restenosis in previously implanted stents.
Gated SPECT (MIBI) myocardial perfusion revealed signiﬁ-
cantly dilated left ventricle (EDV = 290 ml) with a clear non-
perfused apical and anterior zones. Additional akinesis at non-
perfused regions conﬁrmed the diagnosis of anterior-apical
aneurysm. The only lateral and posterior left ventricular walls
were functionally preserved being resulted in LVEF of 24%, the
summed rest score (SRS) of 49 and high volume of affected
myocardium (up to 61%). The additional left ventricular
perfusion protocols matching the wall motion abnormalities
and phase images detected several dissociated foci of
pathological asynchrony and active wall motion inside the
aneurysm. The heterogeneous features of these foci makes
possible to consider them as probable origins of ventricular
arrhythmias (Fig. 1, study I).
According to 24-h Holter ECG almost all spontaneous VT
episodes were preceded by bradycardia and have been usually
triggered by R-on-T premature ventricular beats. Therefore as
the ﬁrst line of treatment strategy the baseline pacing
frequency of ICD was increased from 55 to 70 b.p.m., the dose
of bisoprolol was increased to 7.5 mg/daily. Additional
continuous infusion of amiodarone (600–900 mg/daily) was
started but that produced only temporary effect. Based on
previous history of acute respiratory infection, above men-
tioned laboratory ﬁndings and gated SPECT (MIBI) data the
inﬂammatory hypothesis of ES in our patient have been
suggested. This made us to start glucocorticosteroid therapy
Fig. 1 – Dynamic changes of gated SPECT images on follow-
up. I – study performed on admission to the hospital; II –
study performed after aneurysm resection; III – the last
study performed 5 months after additional catheter
ablation of the VT origin. A – end diastolic perfusion
images, B – wall motion images, C – phase images, D –
histogram of phase images. For study I: A – transmural
decreasing of perfusion at the anterior-apical segments of
left ventricle, at the aneurysm; B – dissociated foci of
pathological active wall motion inside the aneurysm
(indicated by arrows); C – dissociated foci of pathological
asynchrony which topographicaly corresponded to foci of
active wall motion. For study II: Dissociated foci of wall
motion at the aneurysm zone disappeared with only two
focuses of pathological asynchrony at the borders of
former aneurism at the antero-lateral wall left (C). For
study III: Two left foci of pathological asynchrony (C)
preserved their topography but changed their temporal
characteristics, that indicates on changes of their
pathological activity.
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efforts the patient continued to suffer from frequent VT/VF
episodes that required repeated ICD shocks (up to 10 shocks
daily) (Fig. 2). Absolute resistance of ES to pharmacological
therapy, urged us to the surgical management.
Aneurysmectomy with endocardial resection and ultra-
sound destruction of endocardium have been performed
under intra-aortic balloon pumping and continuous intrave-
nous infusion of lidocaine and was accomplished by endo-
ventricular patch plasty repair (Dor's operation). No intra- and
post-operative complications have been noted. During histo-
logical evaluation of aneurysm material there was revealed
massive subendocardial inﬁltration with different inﬂamma-
tory cells (predominantly CD3+ and CD8+ T-cells and CD68+
macrophages, more than 80 cells per 1 mm2). Inﬁltrates were
located among huge areas of connective tissue and sometimes
related to necrotizing cardiomyocytes (Fig. 3). According to
present quantitative immunohistological criteria the persis-
tence of more than 14 inﬂammatory cells per 1 mm2 is enough
for histological diagnosis of active inﬂammation in myocardi-
um [7]. So, these ﬁndings conﬁrmed the diagnosis of acute
myocarditis. The most probable cause of myocarditis in our
patient seemed to be autoimmune since PCR analyses of
aneurysm sample for herpes simplex 1–2 virus, human herpes
6 virus, Epstein-Barr virus, cytomegalovirus, adenovirus,
coxsackie virus B3 and parvovirus B19 was negative. No
additional therapy based on these ﬁndings has been pre-
scribed because of previously unsuccessful experience of
glucocorticoid therapy and lack of standardized treatment
strategies for myocarditis according to present knowledge.
Post-operative echocardiography demonstrated LV reduc-
tion (EDD 6.0 cm, EDV 177 ml), an improvement of LVEF (33%),
with residual akinesia of apical segments due to patch plasty
repair, mild-to-moderate mitral regurgitation and decrease of
PSAP to 28 mmHg. According to repeated gated SPECT (MIBI)
multiple dissociated foci of wall motion abnormalities inside
the aneurysm disappeared. However, two foci of pathological
asynchrony located in antero-lateral wall were still present
(Fig. 1, study II).
The ﬁrst month after surgery passed uncomplicated. A little
later despite continued amiodarone therapy the new onset of ES
consisted of 4 ICD shocks occurred. This prompted to perform
radiofrequency catheter ablation (RFCA). The electrophysiolog-
ical mapping of arrhythmogenic substrate revealed the area of
delayed activation in anterior LV wall which matched topo-
graphically with foci of pathological asynchrony revealed by
SPECT that followed by expanded RFCA.
During next ﬁve months no ICD interventions occurred and
the patient was in stable sinus rhythm on standard HF therapy
and amiodarone. Repeated gated SPECT (MIBI) showed that
two previously observed focuses of pathological asynchrony in
antero-lateral wall had the same topography but changed their
temporal characteristics, what indicated changes of their
pathological activity (Fig. 1, study III).
Discussion
The main ﬁnding in our case is that ES even in post-MI patient
can be initiated by inﬂammatory affection of myocardium. The
Fig. 2 – The ECG with episodes of monomorphic ventricular tachycardia (VT). A,B – examples of successful treatment of VT
with ICD shock. C,D – continuous recording: ICD shock transforms VF into ventricular flutter (C), terminated by ICD shock (D).
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elevated level of peripheral biomarkers (IL6 and b1-AAbs)
made us to suspect myocarditis. The diagnosis of myocarditis
is complex and practically based on both non-invasive and
invasive approaches. Endomyocardial biopsy (EMB) is up to
now the only ‘‘gold standard’’ in the veriﬁcation of myocardial
inﬂammation [7]. The clinical course of our patients (its
relation to episode of viral infection) and the elevated level of
peripheral biomarkers made us to suspect myocarditis.
Among noninvasive strategies the cardiac MRI with late
gadolinium enhancement is the most prominent nowadays
method, which is well standardized for diagnosis of myocar-
ditis [8]. However there is growing evidence that sensitivity
and speciﬁcity of this method in cases of chronic myocarditis
is not high enough [9], moreover it is impossible to use MRI in
patients with implanted pacemaker or ICD. These limitations
of existent visualizing modalities for myocarditis detection led
to searching for other imaging approaches. The chosen gated
SPECT method has helped to solve many tasks: to determine
the size and topography of both scar tissue [10] and viablemyocardium [11]. Special evaluation of phase images which
were previously reported to be useful in dyssynchrony
assessment [12] was performed. Due to this analyses we
detected pathological pre-contractility foci around the aneur-
ysmatic ﬁbrotic tissue indicated the viable myocardium with
possible ectopic activity. In the aspect of heart rhythm
disturbances this method turned out to be representative as
it was noticed in previous publications [13]. The observed foci
were inﬂammatory by their nature and supposed to be VT
origins due to all other ﬁndings.
Myocarditis may cause arrhythmias both in acute phase
due to inﬂammatory inﬁltration and necrosis of the myocytes,
and in its chronic phase due to immune reaction, ﬁbrosis and
ventricular electrical remodeling. Our patient was known to
have large electrically neutral scar zone as the result of
recurrent myocardial infarctions. The so-called ‘‘borderline
zone’’ located at the frontier between scar and viable
myocardium is supposed to be the arrhythmogenic substrate
of ventricular arrhythmias in most post-MI patients [14].
According to modern concept the onset of major VT/VF
Fig. 3 – Histological evaluation of the rejected aneurysm. Light microscopy. A – hematoxyline-eosine staining. The large
infiltrate of lymphocytes and macrophages is detected among the fields of connective tissue. B – Masson's trichrome
staining. Among collagen fibers the same infiltrate could be seen. C–F – immunohistochemistry alkaline phosphatase
staining for CD4+ (C), CD8+ (D), CD68+ (E) and CD3+ (F) inflammatory cells, the cellular nuclei are additionally stained with
hematoxyline.
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arrhythmogenic substrate in ventricular myocardium under
the inﬂuence of speciﬁc triggers and modulating factors. Such
a factor in the present case turned out to be inﬂammation. Our
hypothesis was conﬁrmed by results of histological evaluation
of aneurysm: we found inﬂammatory inﬁltrates in borderline
zone of rejected aneurysmatic sac, which served as a locus
minoris resistentiae predominantly affected during myocarditis.
The existent etiopathogenic strategies of myocarditis
treatment are not well established. There were only few
attempts aimed to develop speciﬁc therapeutic schemes in
myocarditis treatment. One of them was randomized, double-
blind, placebo-controlled study (TIMIC) reported by Frustaci A.
(2009) suggested prednisolone 1 mg kg1 day1 for 4 weeks
followed by 0.33 mg kg1 day1 for 5 months and azathioprine
2 mg kg1 day1 for 6 months in EMB positive myocarditis and
chronic (>6 months) heart failure unresponsive to conven-
tional therapy. Combined therapy (prednisolone andazathioprine) is not recommended until histological conﬁr-
mation of myocarditis and virus persistence exclusion because
virus persistence can result in ineffectiveness of immunosup-
pressive therapy [15]. In our case the relation of ES to episode of
viral infection and the elevated level of peripheral biomarkers
(IL6 and b1-AAbs) made us to suspect myocarditis. Together
with maximal antiarrhythmic therapy we performed unsuc-
cessful attempt to abort the ongoing inﬂammation in
myocardium by using prednisolone relying on importance of
autoimmune injury (high titer of autoantibodies to b1-AAbs). It
should be added that patients with ventricular arrhythmias
were not included in TIMIC trial so there is no data that such
therapy can abort ES. Moreover another one trial (A clinical
trial of immunosuppressive therapy for myocarditis: the
Myocarditis Treatment Trial Investigators) published by
Mason JW et al. at NEMH in 1995 contradicts TIMIC trial. Its
results do not support routine treatment of myocarditis with
immunosuppressive drugs [16].
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treatment no other options were performed to stop inﬂam-
mation. That is why we turned to surgical methods of VT
treatment. Left ventricular aneurysm is a serious complication
of acute myocardial infarction (MI) associated with congestive
heart failure and ventricular tachycardia (VT). It represents an
independent predictor of late sudden cardiac death after acute
MI [17]. Moreover recent study performed by Russo A. (2012)
have clearly demonstrated that in a cases of persisting drug-
refractory VTs after a biopsy-proven myocarditis RFCA is
feasible, safe and effective [18]. Resection of aneurysm with a
portion of inﬂamed myocardium and subsequent RFCA of
residuary inﬂammatory foci interrupted VT recurrence.
Conclusion
ES in post-MI patients at least in some cases may result from
inﬂammatory affection of myocardium. The increased level of
peripheral inﬂammatory biomarkers such as IL6 and b1-AAbs
if observed in patients with ES may reﬂect the current
myocardial inﬂammation. Gated SPECT with phase images
analysis turned out to be a good visualizing method in
detection of pathologic ventricular activity and also for
diagnosis of the potentially reversible causes of ventricular
arrhythmias such as myocarditis.
Taking together our ﬁndings might add some information on
the pathogenesis and predisposing factors of ventricular
arrhythmias especially in the cases of electrical storm. Future
investigations should be performed in order to develop strate-
gies for myocarditis treatment which additionally to surgical
methods can help to interrupt inﬂammatory related VTs.
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